National Healthcare's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is National Healthcare's ROA in the first quarter of 2026?
National Healthcare Corp achieved a return on average assets (ROA) of 8.07 % in its first quarter of 2026, this is above NHC's average return on assets of 7.22%.
National Healthcare Corp assets over the 12 months ending in its first quarter of 2026 are valued at $1,566 million

ROA has improved compared to 7.85% in the fourth quarter of 2025, due to net income growth.

However, within the Healthcare sector 115 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2026 quarter, so far to 749, from total ROA ranking in the fourth quarter of 2025 at 877.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Total Assets Change	1.11 %	8.03 %	6.18 %	23.89 %	25.4 %
Y / Y Net Income Change	11.81 %	317.88 %	-3.96 %	-11.04 %	23 %
Net Income (TTM) in million	126	123	103	105	108
Return On Assets (TTM)	8.07 %	7.85 %	6.75 %	6.96 %	7.54 %
NHC's Total Ranking	# 749	# 877	# 936	# 926	# 870
Total Assets (TTM) in million	1,566	1,565	1,572	1,562	1,549
Seq. Total Assets Change	0.06 %	-0.44 %	0.64 %	0.87 %	6.91 %
Seq. Net Income Change	43.3 %	-38.56 %	70.07 %	-25.32 %	435.58 %

NHC's 5 Years Annual ROA >> Back to NHC Management Effectiveness >> Compare NHC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 12
Sector	# 116
Overall	# 745

Return On Assets Statistics
High	Average	Low
60.29 %	7.22 %	-0.57 %
(Dec 31 2015)

Financial Statements
National Healthcare's Assets	$ 1,566 million	NHC's Balance sheet
National Healthcare's Income	$ 36 million	Quarterly NHC's Income Statement
NHC's Income by Division		See NHC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	8.03 %	18.95 %	5.21 %	-7.36 %	6.45 %
Total Assets in million	1,565	1,449	1,218	1,158	1,249
Y / Y Net Income Change	20.1 %	56.36 %	226.82 %	-85.64 %	231.24 %
Net Income in million	123	102	65	20	139
Annual Return On Assets	7.83 %	7.05 %	5.36 %	1.73 %	11.13 %

NHC's 5 Years Annual ROA >> Back to NHC Management Effectiveness >> Compare NHC ROA to its Competitors

Comment on NHC's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 7.83 % compared to prior year, due to annual net income growth of 20.1 % to $122.61 million, while value of National Healthcare's overall assets grew just by 8.03 % to $1,565.15 million, compared to $1,565.15 a year before.

More Return On Assets Ratios
NHC's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NHC's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NHC's Competitors
Subscribers only: Roa for National Healthcare's Suppliers
Subscribers only: Return On Assets for NHC's Customers

You may also want to know
NHC's Roi	NHC's Inventory Turnover Ratio	NHC's Growth Rates	NHC's Dividend Comparisons
	NHC's Profitability Ratios	NHC's Asset Turnover Ratio	NHC's Dividend Growth
NHC's Roe	NHC's Valuation Ratios	NHC's Financial Strength Ratios	NHC's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2026, within Healthcare Sector	ROA
Incyte Corporation	21.65 %
Iradimed Corporation	21.25 %
Catalyst Pharmaceuticals Inc	20.71 %
Vaxart Inc	20.07 %
Indivior Pharmaceuticals Inc	19.14 %
Engene Therapeutics Inc	18.38 %
Electromed Inc	18.31 %
Pro dex Inc	18.27 %
Soleno Therapeutics Inc	18.25 %
Resmed Inc	18.00 %
Protalix Biotherapeutics inc	17.75 %
Krystal Biotech Inc	17.62 %
Zoetis Inc	17.54 %
United Therapeutics Corporation	17.25 %
Vertex Pharmaceuticals Inc	17.18 %
Chemed Corporation	16.20 %
Gilead Sciences Inc	16.06 %
Transmedics Group Inc	15.85 %
Inspire Medical Systems inc	15.30 %
Neurocrine Biosciences Inc	15.12 %
Strata Critical Medical Inc	15.09 %
Intuitive Surgical Inc	14.98 %
Halozyme Therapeutics Inc	14.73 %
Profound Medical Corp	13.91 %
Aveanna Healthcare Holdings Inc	13.73 %
Standard Biotools Inc	13.58 %
Illumina Inc	13.40 %
Dexcom Inc	13.39 %
West Pharmaceutical Services Inc	13.21 %
Apellis Pharmaceuticals Inc	13.20 %

Date modified: 2026-08-31T07:50:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.